Nektar Therapeutics
NKTR
NKTR
145 hedge funds and large institutions have $1.43B invested in Nektar Therapeutics in 2014 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 59 increasing their positions, 45 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3% less capital invested
Capital invested by funds: $1.48B → $1.43B (-$48.3M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
145
Holding in Top 10
1
Calls
$10.7M
Puts
$2.61M
Top Buyers
| 1 | +$28.2M | |
| 2 | +$12.7M | |
| 3 | +$10.6M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.28M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$5.43M |
Top Sellers
| 1 | -$20.9M | |
| 2 | -$8.35M | |
| 3 | -$6.25M | |
| 4 |
Barclays
London,
United Kingdom
|
-$4.95M |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$3.04M |